HSBC Holdings
XERS icon

HSBC Holdings’s Xeris Biopharma Holdings XERS Stock Holding History

HSBC Holdings’s Portfolio XERS Stock Details XERS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$330K Buy
41,779
+10,604
+34% +$67.7K ﹤0.01% 2468
2026
Q1 		$183K Buy
+31,175
New +$207K ﹤0.01% 2636
2025
Q2 		– Sell
-16,205
Closed -$88K – 3269
2025
Q1 		$88K Sell
16,205
-107
-0.7% -$432 ﹤0.01% 2835
2024
Q4 		$55.5K Sell
16,312
-7,349
-31% -$23.6K ﹤0.01% 2973
2024
Q3 		$67.3K Sell
23,661
-315
-1% -$809 ﹤0.01% 2855
2024
Q2 		$53.5K Sell
23,976
-1,084
-4% -$2.19K ﹤0.01% 2810
2024
Q1 		$55.4K Buy
25,060
+14,444
+136% +$37.4K ﹤0.01% 2929
2023
Q4 		$25.2K Hold
10,616
– – ﹤0.01% 2679
2023
Q3 		$19.8K Hold
10,616
– – ﹤0.01% 2673
2023
Q2 		$27.5K Hold
10,616
– – ﹤0.01% 2510
2023
Q1 		$17.2K Hold
10,616
– – ﹤0.01% 2613
2022
Q4 		$13.5K Hold
10,616
– – ﹤0.01% 3026
2022
Q3 		$17K Hold
10,616
– – ﹤0.01% 2877
2022
Q2 		$16K Sell
10,616
-2,474
-19% -$5.22K ﹤0.01% 3203
2022
Q1 		$34K Sell
13,090
-1,302
-9% -$3.18K ﹤0.01% 3217
2021
Q4 		$42K Sell
14,392
-827
-5% -$1.79K ﹤0.01% 3212
2021
Q3 		$37K Buy
+15,219
New +$44.2K ﹤0.01% 2940

Other funds holding XERS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
RA
Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

HSBC Holdings's XERS Position: Q2 2026 in Review

HSBC Holdings increased its Xeris Biopharma Holdings (XERS) stake by 34% in Q2 2026, buying an estimated $67.7K and bringing the position to 41,779 shares worth $330K. The position accounts for ﹤0.01% of the portfolio, ranked #2468.

HSBC Holdings first reported a position in XERS in Q3 2021 and has held it in 17 quarters since. 241 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

  • HSBC Holdings held 41,779 shares of Xeris Biopharma Holdings worth $330K as of Q2 2026.
  • HSBC Holdings bought 10,604 Xeris Biopharma Holdings shares in Q2 2026, an estimated $67.7K.
  • Xeris Biopharma Holdings made up ﹤0.01% of HSBC Holdings's portfolio in Q2 2026, its #2468 holding.
  • HSBC Holdings first reported a position in Xeris Biopharma Holdings in Q3 2021 and has held it in 17 quarters since.
  • 241 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on HSBC Holdings's 13F filing for Q2 2026, filed 14 Aug 2026.